Amakem Therapeutics
Industry
- Pharmaceuticals
Other Names/Subsidiaries
- Amakem NV
Latest on Amakem Therapeutics
Start-Up Execs Acella Pharmaceuticals LLC Tom Larkin To:VP, Sales & Mktg. (May) From:Pres., Major Pharmaceuticals Tel:678-325-5189 Advanced Cardiac Therapeutics Inc. Bill Olson To:Pres. & CEO
Total funds raised by private biotechs in Europe fell to $831 million in 2011, down 17% compared with 2010, according to Elsevier’s Strategic Transactions database, as the region’s sovereign debt and
Financings In the third quarter of 2011, biopharma start-ups raised $299 million – $48 million more than last quarter, with more than half of the funding going to Series A rounds. ( See Exhibit 1. )Me
Financings The third quarter of 2011 saw biopharmaceutical financings slump in both the number of transactions and the amount of money raised. The 61 financings that closed brought in $1.3 billion, we